Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00208949 · ClinicalTrials.gov registry record · Phase 2

A Comparison of Dendritic Cell Content and T-Cell Phenotype Between Granulocyte Colony-Stimulating Factor (G-CSF) or G-CSF + Granulocyte Macrophage (GM)-CSF

A Phase 2 study, sponsored by Emory University.

Terminated
Registry status
Phase 2
Development phase
50
Enrollment target

NCT00208949: Clinical Trial Phase 2 study, sponsored by Emory University.

NCT00208949 is a Phase 2 study that was terminated before completion, run by Emory University. The registered enrollment target is 50 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (62% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00208949, a Phase 2 study, was terminated before completion, sponsored by Emory University.

TERMINATED
Registry status
Phase 2
Development phase
50 participants
Enrollment target

Study Summary

This is a study involving patients who are undergoing allogeneic peripheral blood stem cell transplantation. Both donors and recipients are being sought for this study.

Interventions

  • DRUG G-CSF
  • DRUG GM-CSF

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2002-09
Est. Completion 2012-05
Phase Phase 2
Emory University

1,208 total trials

Why NCT00208949 stopped before completion

NCT00208949 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (62% lower).

The record links to 0 conditions, and to 2 interventions - of which G-CSF is the first listed.

NCT00208949 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00208949 about?

NCT00208949 is a clinical study titled "A Comparison of Dendritic Cell Content and T-Cell Phenotype Between Granulocyte Colony-Stimulating Factor (G-CSF) or G-CSF + Granulocyte Macrophage (GM)-CSF". This is a study involving patients who are undergoing allogeneic peripheral blood stem cell transplantation. Both donors and recipients are being sought for this study.

What is the current status of trial NCT00208949?

This trial is currently terminated. It is a Phase 2 study. The enrollment target is 50 participants. The study started on 2002-09. Estimated completion is 2012-05.

What interventions are being tested in trial NCT00208949?

The interventions under investigation include: G-CSF (DRUG), GM-CSF (DRUG).

Who is sponsoring clinical trial NCT00208949?

This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00208949's enrollment target sits among peer trials

50 1195th of 2000 higher than 740 of 2,000 other Phase 2 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00200889 · 50 participants · Early Phase 1

    Mapping Auricular Vagus Nerve Circuitry

  • NCT00409435 · 50 participants · Phase 2

    A Study of Pyridostigmine in Postural Tachycardia Syndrome

  • NCT01202305 · 50 participants

    The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies

  • NCT01225913 · 50 participants · Phase 4

    Mechanism(s) of Airflow Limitation During Exacerbation of Asthma

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00208949, the US trial registry maintained by the National Library of Medicine. NCT00208949 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.